2015
DOI: 10.1016/j.genhosppsych.2015.05.011
|View full text |Cite
|
Sign up to set email alerts
|

The Montreal Cognitive Assessment as a preliminary assessment tool in general psychiatry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 23 publications
0
15
0
Order By: Relevance
“…Demographic information was collected via self-report, and the Montreal Cognitive Assessment (MoCA; Nasreddine et al 2005) was used to screen for cognitive impairment. A score lower than the age/education-adjusted cutoff for psychiatric populations (Gierus et al 2015) triggered additional neuropsychological evaluation and clinician clearance to participate. The Mini International Neuropsychiatric Interview (MINI 6.0; Sheehan et al 1998) was used to establish psychiatric diagnoses, including primary diagnosis, and to screen for suicide/homicide risk.…”
Section: Methodsmentioning
confidence: 99%
“…Demographic information was collected via self-report, and the Montreal Cognitive Assessment (MoCA; Nasreddine et al 2005) was used to screen for cognitive impairment. A score lower than the age/education-adjusted cutoff for psychiatric populations (Gierus et al 2015) triggered additional neuropsychological evaluation and clinician clearance to participate. The Mini International Neuropsychiatric Interview (MINI 6.0; Sheehan et al 1998) was used to establish psychiatric diagnoses, including primary diagnosis, and to screen for suicide/homicide risk.…”
Section: Methodsmentioning
confidence: 99%
“…Defining a single, optimal MoCA cutoff score from the large number of validation studies is further limited by the fact that the majority of studies have been conducted in specific patient populations, such as those with cerebrovascular conditions (e.g., Cumming et al, 2013;Dong et al, 2010Dong et al, , 2012Freitas et al, 2012b;Godefroy et al, 2011;Pendlebury et al, 2012Pendlebury et al, , 2013Webb et al, 2014;Wong, Lam, et al, 2013a) cardiovascular conditions (Hawkins et al, 2014;McLennan et al, 2011), Parkinson's disease (e.g., Chen et al, 2013;Dalrymple-Alford et al, 2010;Gill et al, 2008;Hoops et al, 2009;Kasten et al, 2010;Krishnan et al, 2015;Ozdilek & Kenangil, 2014;Sobreira et al, 2015), HIV (Koski et al, 2011;Milanini et al, 2014;Janssen et al, 2015;Joska et al, 2016;Overton et al, 2013), Traumatic Brain Injury (Wong, Ngai, et al, 2013b), psychiatric conditions (Gierus et al, 2015;Musso et al, 2014), Huntington disease (Bezdicek et al, 2013), and Korsokoff syndrome (Oudman et al, 2014;Wester et al, 2013).…”
mentioning
confidence: 99%
“…The Montreal Cognitive Assessment 1 (MoCA [ 28 ]; is a brief (~10 min) clinician-administered cognitive screening test, which will be used to screen for cognitive impairment. If the score is < 22, which has been identified an as appropriate cutoff for psychiatric patients [ 29 ], patients will be referred for additional evaluation and excluded, unless a qualified clinician provides clearance to participate. The blind version of the MoCA, which is the same as the MoCA except for the removal of visual items, is used for remote assessments.…”
Section: Methodsmentioning
confidence: 99%